Filing Details
- Accession Number:
- 0000950170-25-097599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-22 17:00:05
- Reporting Period:
- 2025-07-18
- Filing Date:
- 2025-07-22
- Accepted Time:
- 2025-07-22 17:00:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1971543 | Mural Oncology Plc | MURA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1693805 | Maiken Keson-Brookes | C/O Mural Oncology Plc 10 Earlsfort Terrace Dublin 2 L2 D02 T380 | See Remarks | No | No | No | No |
Transaction Summary
Sold: | 2,158 shares | Avg. Price: $2.48 | Total Value: $5,351.84 |
Number of Shares After Transactions: | 71,406 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2025-07-18 | 2,158 | $2.48 | 71,406 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on December 22, 2023, and the sale does not represent a discretionary trade by the Reporting Person.
- Includes 62,203 unvested restricted stock units.